ORIENTBIO Inc. (002630) — Cash Flow Reinvestment Rate
ORIENTBIO Inc. (002630) has a Cash Flow Reinvestment Rate of 0.26x as of December 2025, reinvesting ₩467.25 Million (capex ₩452.25 Million plus investments ₩-15.00 Million) from operating cash flow of ₩1.77 Billion. Explore 002630 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ORIENTBIO Inc. Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ORIENTBIO Inc. across 12 annual periods. Also explore 002630 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ORIENTBIO Inc. (2007–2025)
Year-by-year capital reinvestment analysis for ORIENTBIO Inc.. For live market cap and broader valuation context, see how much is ORIENTBIO Inc. worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.67x | ₩5.77 Billion | ₩752.29 Million | ₩4.79 Billion | ▲ +2420.9% |
| 2024 | 0.30x | ₩1.14 Billion | ₩3.76 Billion | ₩925.25 Million | ▼ -98.1% |
| 2023 | 16.12x | ₩18.70 Billion | ₩1.16 Billion | ₩485.64 Million | ▲ +314.8% |
| 2022 | 3.89x | ₩9.14 Billion | ₩2.35 Billion | ₩2.21 Billion | ▲ +8953.9% |
| 2021 | 0.04x | ₩375.16 Million | ₩8.74 Billion | ₩256.16 Million | ▼ -99.7% |
| 2016 | 16.17x | ₩14.76 Billion | ₩912.43 Million | ₩14.46 Billion | ▲ +233.8% |
| 2015 | 4.84x | ₩7.77 Billion | ₩1.60 Billion | ₩5.11 Billion | ▼ 0.0% |
| 2014 | 4.85x | ₩10.51 Billion | ₩2.17 Billion | ₩10.43 Billion | ▲ +30.3% |
| 2013 | 3.72x | ₩18.94 Billion | ₩5.09 Billion | ₩18.94 Billion | ▲ +289.9% |
| 2011 | 0.95x | ₩2.97 Billion | ₩3.11 Billion | ₩2.97 Billion | ▲ +460.7% |
| 2010 | 0.17x | ₩1.59 Billion | ₩9.35 Billion | ₩1.59 Billion | ▼ -97.9% |
| 2007 | 8.11x | ₩12.30 Billion | ₩1.52 Billion | ₩12.30 Billion | — |